An AFP (alpha - fetoprotein) tumor marker test measures the level of AFP, a protein normally produced by the fetal liver, in the blood.While AFP levels are typically very low in adults, elevated levels can indicate certain types of cancer, such as liver cancer, testicular cancer, or ovarian cancer.This test is used as part of cancer diagnosis, monitoring treatment response, and detecting potential recurrence.Its important to note that elevated AFP levels can also be caused by other conditions, such as liver damage or inflammation.

THE CA 19-9 TEST MEASURES THE LEVEL OF A SPECIFIC PROTEIN (CA 19-9) IN THE BLOOD. WHILE ELEVATED CA 19-9 LEVELS ARE OFTEN ASSOCIATED WITH PANCREATIC CANCER, ITS IMPORTANT TO NOTE THAT THIS TEST ISNOT SPECIFIC TO PANCREATIC CANCER AND CAN BE ELEVATED IN OTHER CONDITIONS LIKE LIVER DISEASE, GALLBLADDER INFLAMMATION, OR EVEN SOME BENIGN PANCREATIC DISEASES. THEREFORE, CA 19-9 IS PRIMARILY USED TO MONITOR THE PROGRESSION OF KNOWN PANCREATIC CANCER, RATHER THAN AS A SCREENING TOOL. OTHER DIAGNOSTIC TESTS, SUCH AS IMAGING STUDIES, ARE CRUCIAL FOR CONFIRMING PANCREATIC CANCER.

LDH IS AN ENZYME FOUND IN VARIOUS TISSUES THROUGHOUT THE BODY, INCLUDING THE HEART, LIVER, SKELETAL MUSCLE, KIDNEYS, AND RED BLOOD CELLS. IT IS INVOLVED IN THE BREAKDOWN OF GLUCOSE FOR ENERGY PRODUCTION. WHEN TISSUES ARE DAMAGED OR DISEASED, LDH LEVELS IN THE BLOOD CAN INCREASE. ELEVATED LDH LEVELS CAN BE A SIGN OF CONDITIONS SUCH AS HEART ATTACKS, LIVER DISEASE, HEMOLYTIC ANEMIA, MUSCLE DAMAGE, AND CERTAIN CANCERS. HOWEVER, IT IS IMPORTANT TO NOTE THAT ELEVATED LDH LEVELS ALONE MAY NOT BE ENOUGH TO DIAGNOSE A SPECIFIC CONDITION, AND FURTHER TESTING MAY BE NECESSARY TO DETERMINE THE UNDERLYING CAUSE.

Carcinoembryonic antigen (CEA) is a glycoprotein produced by the fetal digestive tract and certain types of cancer cells.While elevated CEA levels can indicate various cancers, including colorectal, lung, breast, and pancreatic, Its not a definitive diagnostic tool. CEA testing is primarily used to monitor treatment response, detect cancer recurrence, and assess prognosis in individuals with known cancer.

PSA (PROSTATE-SPECIFIC ANTIGEN) FREE IS A BLOOD TEST THAT MEASURES THE AMOUNT OF UNBOUND OR FREE PSA IN THE BLOODSTREAM. PSA, A PROTEIN PRODUCED BY THE PROSTATE GLAND, CAN CIRCULATE FREELY OR BOUND TO OTHER PROTEINS. BY MEASURING THE FREE PSA LEVEL AND COMPARING IT TO THE TOTAL PSA (WHICH INCLUDES BOTH FREE AND BOUND PSA), HEALTHCARE PROVIDERS CAN GAIN MORE INFORMATION ABOUT THE POTENTIAL CAUSE OF AN ELEVATED PSA. A LOWER PERCENTAGE OF FREE PSA IS OFTEN ASSOCIATED WITH AN INCREASED RISK OF PROSTATE CANCER, BUT FURTHER EVALUATION IS NECESSARY FOR DIAGNOSIS.

PSA (PROSTATE-SPECIFIC ANTIGEN) TOTAL IS A BLOOD TEST USED TO SCREEN FOR PROSTATE CANCER. PSA IS A PROTEIN PRODUCED BY THE PROSTATE GLAND, AND ELEVATED LEVELS CAN INDICATE PROSTATE CANCER OR OTHER PROSTATE PROBLEMS LIKE BENIGN PROSTATIC HYPERPLASIA (BPH). HOWEVER, ITS IMPORTANT TO NOTE THAT PSA LEVELS CAN ALSO BE RAISED BY FACTORS OTHER THAN CANCER, SUCH AS PROSTATE INFLAMMATION OR AN ENLARGED PROSTATE. THEREFORE, PSA TESTING SHOULD BE USED IN CONJUNCTION WITH OTHER DIAGNOSTIC TESTS TO EVALUATE PROSTATE HEALTH.

HCG IS A HORMONE PRODUCED BY THE SYNCYTIOTROPHOBLAST OF THE PLACENTA. HCG CONCENTRATIONS ARE INCREASED IN CASES OF TESTICULAR TUMORS, OVARIAN GERM CELL TUMORS AND GESTATIONAL TROPHOBLASTIC DISEASE.

A COMPLETE BLOOD COUNT (CBC) IS A COMPREHENSIVE BLOOD TEST THAT PROVIDES INFORMATION ABOUT THE CELLS IN YOUR BLOOD. IT MEASURES THE NUMBER OF RED BLOOD CELLS, WHITE BLOOD CELLS, AND PLATELETS, AS WELL AS HEMOGLOBIN (THE PROTEIN THAT CARRIES OXYGEN) AND HEMATOCRIT (THE PERCENTAGE OF RED BLOOD CELLS IN YOUR BLOOD). A CBC IS USED TO DIAGNOSE AND MONITOR A WIDE RANGE OF CONDITIONS, INCLUDING ANEMIA, INFECTIONS, BLEEDING DISORDERS, AND BLOOD CANCERS.